96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

209 trials found

diseases per page:

Showing 1 to 10 of 209 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05660746 (ClinicalTrials.gov)	April 1, 2023	29/11/2022	Precise Infliximab Exposure and Pharmacodynamic Control	Precise InfliximabExposure and Pharmacodynamic Control to Achieve Deep Remission in Pediatric Crohn' ...	Crohn Disease	Device: RoadMAB;Drug: Infliximab	Children's Hospital Medical Center, Cincinnati	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Janssen Scientific Affairs, ...	Not yet recruiting	6 Years	22 Years	All	180	Phase 2/Phase 3	United States
2	NCT05584228 (ClinicalTrials.gov)	April 1, 2023	26/9/2022	Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease	SyMptomAtic Stricturing Small Bowel CRohn's Disease - Medical Treatment Versus Surgery, a Prospectiv ...	Crohn Disease	Drug: Azathioprine + infliximab;Procedure: Intestinal resection	Nantes University Hospital	Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives	Not yet recruiting	18 Years	70 Years	All	150	N/A	NULL
3	NCT05552287 (ClinicalTrials.gov)	March 2023	11/7/2022	Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease	Prospective Analysis of Pharmacokinetic Infliximab Data in Pediatric CD Patients (ProRAPID)	Crohn Disease;Child, Only;Biologic; Inadequate	Drug: Infliximab	Erasmus Medical Center	NULL	Not yet recruiting	3 Years	15 Years	All	50	Phase 4	NULL
4	EUCTR2022-002648-35-NL (EUCTR)	04/01/2023	22/11/2022	Prospective Analysis of Pharmacokinetic Infliximab Data in pediatric CDpatients	Prospective Analysis of Pharmacokinetic Infliximab Data in pediatric CDpatients - PRO-RAPID	Crohn's disease;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Product Name: Infliximab	Erasmus Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 4	Netherlands;Italy
5	NCT05043870 (ClinicalTrials.gov)	October 10, 2022	2/9/2021	Combined Immunosuppression for Pediatric Crohn's Disease	Combination Therapy of Infliximab and Immunosuppressives for Pediatric Crohn's Disease	Crohn Disease;Infliximab;Immunosuppression;Children, Only	Drug: Infliximab and immunosuppressives;Drug: Infliximab	Children's Hospital of Fudan University	NULL	Recruiting	6 Years	18 Years	All	128	Phase 4	China
6	EUCTR2020-001811-26-BE (EUCTR)	18/11/2021	22/07/2021	IBD under control with less medication	De-escalation of anti-TNF therapy in adolescents and young adults with IBD with tight faecal calprot ...	Crohn's disease, ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] ...	Trade Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Flixabi INN or Proposed INN: INFLIXIMA ...	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	148	Phase 4	Belgium;Netherlands
7	NCT04835506 (ClinicalTrials.gov)	November 1, 2021	5/4/2021	Proactive InfliximabOptimization Using a PK Dashboard Versus SOC in Patients With Crohn's Disease: T ...	Proactive InfliximabOptimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patien ...	Crohn Disease	Drug: Infliximab	Beth Israel Deaconess Medical Center	The Leona M. and Harry B. Helmsley Charitable Trust;Icahn School of Medicine at Mount Sinai	Enrolling by invitation	16 Years	N/A	All	196	Phase 4	United States
8	EUCTR2021-000469-33-NL (EUCTR)	12/10/2021	25/03/2021	Scientific medical research comparing the effectiveness of Infliximabby injection in the abdominal t ...	A Prospective Multicenter Randomized Controlled, Open-label Study to Compare the Efficacy of Subcuta ...	Crohns disease;Therapeutic area: Body processes [G] - Biological Phenomena [G16]	Trade Name: Remsima Product Name: Remsima Product Code: EMEA/H/C/002576 Trade Name: Puri Nethol Product ...	Amsterdam UMC location AMC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	158	Phase 3;Phase 4	Netherlands
9	NCT04974099 (ClinicalTrials.gov)	October 1, 2021	29/6/2021	Personalized InfliximabInduction Strategy With Model-informed Dosing in Patients With Crohn's Diseas ...	Personalized InfliximabInduction Strategy With Model-informed Dosing in Patients With Crohn's Diseas ...	Crohn Disease	Device: RoadMAB;Drug: Precision dosing with a dashboard	Children's Hospital Medical Center, Cincinnati	Crohn's and Colitis Foundation	Recruiting	6 Years	22 Years	All	20	Phase 2/Phase 3	United States
10	EUCTR2019-002942-19-DK (EUCTR)	12/03/2021	05/11/2020	Nordic study of treatment strategy in inflammatory bowel disease	NORDTREATThe Nordic IBD treatment strategy trial – a randomized controlled trial of access to a prot ...	Crohn's disease and Ulcerative colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365; ...	Trade Name: Remicade INN or Proposed INN: INFLIXIMAB Trade Name: Humira INN or Proposed INN: ADALIMUMAB ...	Region Örebro län	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	250	Phase 4	Denmark

First Previous1 2 3 4 5…21Next Last